{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:34:29Z","timestamp":1790634869758,"version":"4.1.0"},"reference-count":154,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T00:00:00Z","timestamp":1610409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genome Ed."],"abstract":"<jats:p>Neurological disorder is a general term used for diseases affecting the function of the brain and nervous system. Those include a broad range of diseases from developmental disorders (e.g., Autism) over injury related disorders (e.g., stroke and brain tumors) to age related neurodegeneration (e.g., Alzheimer's disease), affecting up to 1 billion people worldwide. For most of those disorders, no curative treatment exists leaving symptomatic treatment as the primary mean of alleviation. Human induced pluripotent stem cells (hiPSC) in combination with animal models have been instrumental to foster our understanding of underlying disease mechanisms in the brain. Of specific interest are patient derived hiPSC which allow for targeted gene editing in the cases of known mutations. Such personalized treatment would include (1) acquisition of primary cells from the patient, (2) reprogramming of those into hiPSC via non-integrative methods, (3) corrective intervention via CRISPR-Cas9 gene editing of mutations, (4) quality control to ensure successful correction and absence of off-target effects, and (5) subsequent transplantation of hiPSC or pre-differentiated precursor cells for cell replacement therapies. This would be the ideal scenario but it is time consuming and expensive. Therefore, it would be of great benefit if transplanted hiPSC could be modulated to become invisible to the recipient's immune system, avoiding graft rejection and allowing for allogenic transplantations. This review will focus on the current status of gene editing to generate non-immunogenic hiPSC and how these cells can be used to treat neurological disorders by using cell replacement therapy. By providing an overview of current limitations and challenges in stem cell replacement therapies and the treatment of neurological disorders, this review outlines how gene editing and non-immunogenic hiPSC can contribute and pave the road for new therapeutic advances. Finally, the combination of using non-immunogenic hiPSC and <jats:italic>in vivo<\/jats:italic> animal modeling will highlight the importance of models with translational value for safety efficacy testing; before embarking on human trials.<\/jats:p>","DOI":"10.3389\/fgeed.2020.623717","type":"journal-article","created":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T08:32:52Z","timestamp":1610526772000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Non-immunogenic Induced Pluripotent Stem Cells, a Promising Way Forward for Allogenic Transplantations for Neurological Disorders"],"prefix":"10.3389","volume":"2","author":[{"given":"Henriette Reventlow","family":"Frederiksen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrik","family":"Doehn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pernille","family":"Tveden-Nyborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine K.","family":"Freude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,1,12]]},"reference":[{"key":"B1","volume-title":"Basic Immunology: Functions and Disorders of the Immune System","author":"Abbas","year":"2009"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.neuron.2012.01.020","article-title":"Neuroprotection from stroke in the absence of MHCI or PirB","volume":"73","author":"Adelson","year":"2012","journal-title":"Neuron"},{"key":"B3","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1177\/0883073811422831","article-title":"Catastrophic demyelinating encephalomyelitis after intrathecal and intravenous stem cell transplantation in a patient with multiple sclerosis","volume":"27","author":"Alderazi","year":"2012","journal-title":"J. Child Neurol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.stem.2012.04.026","article-title":"Genetic correction of Huntington's disease phenotypes in induced pluripotent stem cells","volume":"11","author":"An","year":"2012","journal-title":"Cell Stem Cell"},{"key":"B5","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.stemcr.2015.07.011","article-title":"A safeguard system for induced pluripotent stem cell-derived rejuvenated T cell therapy","volume":"5","author":"Ando","year":"2015","journal-title":"Stem Cell Rep"},{"key":"B6","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/nature11807","article-title":"Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells","volume":"494","author":"Araki","year":"2013","journal-title":"Nature"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1242\/dev.097394","article-title":"How to make a midbrain dopaminergic neuron","volume":"142","author":"Arenas","year":"2015","journal-title":"Development"},{"key":"B8","doi-asserted-by":"publisher","first-page":"4357","DOI":"10.1038\/s41467-019-12324-0","article-title":"MHC matching fails to prevent long-term rejection of iPSC-derived neurons in non-human primates","volume":"10","author":"Aron Badin","year":"2019","journal-title":"Nat. Commun"},{"key":"B9","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s12031-008-9166-3","article-title":"Induction of adult human bone marrow mesenchymal stromal cells into functional astrocyte-like cells: potential for restorative treatment in Parkinson's disease","volume":"39","author":"Bahat-Stroomza","year":"2009","journal-title":"J. Mol. Neurosci"},{"key":"B10","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.stem.2017.09.014","article-title":"Human trials of stem cell-derived dopamine neurons for Parkinson's disease: dawn of a new era","volume":"21","author":"Barker","year":"2017","journal-title":"Cell Stem Cell"},{"key":"B11","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1002\/sctm.17-0282","article-title":"Concise review: a comprehensive analysis of reported adverse events in patients receiving unproven stem cell-based interventions","volume":"7","author":"Bauer","year":"2018","journal-title":"Stem Cells Transl. Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/j.1528-1167.2012.03712.x","article-title":"Why are antiepileptic drugs used for nonepileptic conditions?","volume":"53","author":"Bialer","year":"2012","journal-title":"Epilepsia"},{"key":"B13","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1161\/CIRCRESAHA.116.308398","article-title":"Stroke risk factors, genetics, and prevention","volume":"120","author":"Boehme","year":"2017","journal-title":"Circ. Res"},{"key":"B14","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1089\/scd.2012.0052","article-title":"Derivation and characterization of induced pluripotent stem cells lines with inactivation of the beta-2-microglobulin gene by CRISPR\/Cas9 genome editing","volume":"8","author":"Bogomiakova","year":"2018","journal-title":"FEBS Open Biol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1089\/scd.2017.0058","article-title":"An efficient method for generation of knockout human embryonic stem cells using CRISPR\/Cas9 system","volume":"26","author":"Bohaciakova","year":"2017","journal-title":"Stem Cells Dev"},{"key":"B16","doi-asserted-by":"publisher","first-page":"274","DOI":"10.2119\/molmed.2015.00235","article-title":"Generation of hla-universal ipsc-derived megakaryocytes and platelets for survival under refractoriness conditions","volume":"22","author":"B\u00f6rger","year":"2016","journal-title":"Mol. Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1038\/35869","article-title":"HLA-E binds to natural killer cell receptors CD94\/NKG2A, B and C","volume":"391","author":"Braud","year":"1998","journal-title":"Nature"},{"key":"B18","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.jvir.2010.01.008","article-title":"Intraarterial autologous implantation of adult stem cells for patients with Parkinson disease","volume":"21","author":"Brazzini","year":"2010","journal-title":"J. Vasc. Interv. Radiol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1093\/brain\/123.7.1380","article-title":"Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease","volume":"123","author":"Brundin","year":"2000","journal-title":"Brain"},{"key":"B20","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s12967-016-0880-2","article-title":"Finding a new therapeutic approach for no-option Parkinsonisms: mesenchymal stromal cells for progressive supranuclear palsy","volume":"14","author":"Canesi","year":"2016","journal-title":"J. Transl. Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.nmd.2012.09.005","article-title":"Stem cells in severe infantile spinal muscular atrophy (SMA1)","volume":"22","author":"Carrozzi","year":"2012","journal-title":"Neuromusc. Disord"},{"key":"B22","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3389\/fnana.2014.00114","article-title":"Neuronal MHC-i expression and its implications in synaptic function, Axonal regeneration and Parkinson's and other brain diseases","volume":"8","author":"Cebri\u00e1n","year":"","journal-title":"Front. Neuroanat"},{"key":"B23","doi-asserted-by":"publisher","first-page":"4633","DOI":"10.1038\/ncomms4633","article-title":"MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration","volume":"5","author":"Cebri\u00e1n","year":"","journal-title":"Nat. Commun"},{"key":"B24","article-title":"Selection of autologous or allogeneic transplantation","volume-title":"Holland-Frei Cancer Medicine","author":"Champlin","year":"2003"},{"key":"B25","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s40659-015-0051-6","article-title":"Functional disruption of human leukocyte antigen II in human embryonic stem cell","volume":"48","author":"Chen","year":"2015","journal-title":"Biol. Res"},{"key":"B26","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.3892\/mmr.2016.4948","article-title":"Role of neuroinflammation in neurodegenerative diseases (Review)","volume":"13","author":"Chen","year":"2016","journal-title":"Mol. Med. Rep"},{"key":"B27","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1101\/gr.162339.113","article-title":"Analysis of off-target effects of CRISPR\/Cas-derived RNA-guided endonucleases and nickases","volume":"24","author":"Cho","year":"2014","journal-title":"Genome Res"},{"key":"B28","doi-asserted-by":"publisher","first-page":"14069","DOI":"10.1073\/pnas.0507063102","article-title":"Human neural stem cells differentiate and promote locomotor recovery in spinal cord-injured mice","volume":"102","author":"Cummings","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"B29","doi-asserted-by":"publisher","first-page":"4903","DOI":"10.1038\/ncomms4903","article-title":"Transplanted terminally differentiated induced pluripotent stem cells are accepted by immune mechanisms similar to self-tolerance","volume":"5","author":"De Almeida","year":"2014","journal-title":"Nat. Commun"},{"key":"B30","doi-asserted-by":"publisher","first-page":"3215","DOI":"10.1172\/JCI74664","article-title":"Remote control of induced dopaminergic neurons in Parkinsonian rats","volume":"124","author":"Dell'Anno","year":"2014","journal-title":"J. Clin. Invest"},{"key":"B31","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/s41587-019-0016-3","article-title":"Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients","volume":"37","author":"Deuse","year":"2019","journal-title":"Nat. Biotechnol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1242\/jcs.087718","article-title":"Immunobiology of na\u00efve and genetically modified HLA-class-I-knockdown human embryonic stem cells","volume":"124","author":"Deuse","year":"2011","journal-title":"J. Cell Sci"},{"key":"B33","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1634\/stemcells.2005-0188","article-title":"Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells","volume":"24","author":"Drukker","year":"2006","journal-title":"Stem Cells"},{"key":"B34","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1097\/FJC.0b013e318247f642","article-title":"Induced pluripotent stem cells as a disease modeling and drug screening platform","volume":"60","author":"Ebert","year":"2012","journal-title":"J. Cardiovasc. Pharmacol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"136","DOI":"10.3389\/fnmol.2018.00136","article-title":"Brain region-dependent rejection of neural precursor cell transplants","volume":"11","author":"Fainstein","year":"2018","journal-title":"Front. Mol. Neurosci"},{"key":"B36","doi-asserted-by":"publisher","first-page":"101403","DOI":"10.1016\/j.scr.2019.101403","article-title":"Generation of two isogenic iPSC lines with either a heterozygous or a homozygous E280A mutation in the PSEN1 gene","volume":"35","author":"Frederiksen","year":"2019","journal-title":"Stem Cell Res"},{"key":"B37","doi-asserted-by":"publisher","first-page":"681","DOI":"10.3727\/096368915X687769","article-title":"Proof of concept studies exploring the safety and functional activity of human parthenogenetic-derived neural stem cells for the treatment of Parkinson's disease","volume":"24","author":"Gonzalez","year":"2015","journal-title":"Cell Transplant"},{"key":"B38","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/nature09805","article-title":"Somatic coding mutations in human induced pluripotent stem cells","volume":"471","author":"Gore","year":"2011","journal-title":"Nature"},{"key":"B39","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/nbt.3860","article-title":"HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells","volume":"35","author":"Gornalusse","year":"2017","journal-title":"Nat. Biotechnol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s12974-020-01819-z","article-title":"A primary neural cell culture model to study neuron, astrocyte, and microglia interactions in neuroinflammation","volume":"17","author":"Goshi","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"B41","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1600-065X.1997.tb00978.x","article-title":"Human minor histocompatibility antigens: new concepts for marrow transplantation and adoptive immunotherapy","volume":"157","author":"Goulmy","year":"1997","journal-title":"Immunol. Rev"},{"key":"B42","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1080\/13543784.2019.1627324","article-title":"Stem cell treatments for amyotrophic lateral sclerosis: a critical overview of early phase trials","volume":"28","author":"Goutman","year":"2019","journal-title":"Expert Opin. Investig. Drugs"},{"key":"B43","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s13311-011-0068-7","article-title":"Stem cell transplantation for motor neuron disease: current approaches and future perspectives","volume":"8","author":"Gowing","year":"2011","journal-title":"Neurotherapeutics"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1634\/stemcells.2008.0111","article-title":"Costimulation blockade induces tolerance to HESC transplanted to the testis and induces regulatory T-cells to HESC transplanted into the heart","volume":"26","author":"Grinnemo","year":"2008","journal-title":"Stem Cells"},{"key":"B45","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.stem.2013.01.006","article-title":"Lack of immune response to differentiated cells derived from syngeneic induced pluripotent stem cells","volume":"12","author":"Guha","year":"2013","journal-title":"Cell Stem Cell"},{"key":"B46","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.stem.2015.01.018","article-title":"Successful function of autologous iPSC-derived dopamine neurons following transplantation in a non-human primate model of Parkinson's disease","volume":"16","author":"Hallett","year":"2015","journal-title":"Cell Stem Cell"},{"key":"B47","doi-asserted-by":"publisher","first-page":"e85","DOI":"10.1093\/nar\/gkw064","article-title":"Knock-in of large reporter genes in human cells via CRISPR\/Cas9-induced homology-dependent and independent DNA repair","volume":"44","author":"He","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"B48","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1001\/archneur.1991.00530200062020","article-title":"Implantation of human fetal ventral mesencephalon to the right caudate nucleus in advanced Parkinson's disease","volume":"48","author":"Henderson","year":"1991","journal-title":"Arch. Neurol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1097\/CJI.0000000000000176","article-title":"Antigen presentation by individually transferred HLA class I genes in HLA-A, HLA-B, HLA-C null human cell line generated using the multiplex CRISPR-Cas9 system","volume":"40","author":"Hong","year":"2017","journal-title":"J. Immunother"},{"key":"B50","unstructured":"2020"},{"key":"B51","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/jnc.12625","article-title":"Modeling human neurological disorders with induced pluripotent stem cells","volume":"129","author":"Imaizumi","year":"2014","journal-title":"J. Neurochem"},{"key":"B52","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1136\/jnnp.2003.021865","article-title":"Brain tissue loss occurs after suppression of enhancement in patients with multiple sclerosis treated with autologous haematopoietic stem cell transplantation","volume":"75","author":"Inglese","year":"2004","journal-title":"J. Neurol. Neurosurg. Psychiatr"},{"key":"B53","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.stemcr.2017.02.003","article-title":"Fail-safe system against potential tumorigenicity after transplantation of iPSC derivatives","volume":"8","author":"Itakura","year":"2017","journal-title":"Stem Cell Rep"},{"key":"B54","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.omtn.2019.02.009","article-title":"The chromatin structure of CRISPR-Cas9 target DNA controls the balance between mutagenic and homology-directed gene-editing events","volume":"16","author":"Janssen","year":"2019","journal-title":"Mol Ther Nucleic Acids"},{"key":"B55","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A programmable dual-RNA\u2013guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"key":"B56","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1056\/NEJMoa071074","article-title":"HLA-mismatched renal transplantation without maintenance immunosuppression","volume":"358","author":"Kawai","year":"2008","journal-title":"N. Engl. J. Med"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1111\/ajt.12731","article-title":"Long-term results in recipients of combined HLA-mismatched kidney and bone marrow transplantation without maintenance immunosuppression","volume":"14","author":"Kawai","year":"2014","journal-title":"Am. J. Transplant"},{"key":"B58","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s00401-008-0465-0","article-title":"A patient with huntington's disease and long-surviving fetal neural transplants that developed mass lesions","volume":"117","author":"Keene","year":"2009","journal-title":"Acta Neuropathol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"11839","DOI":"10.1073\/pnas.0404474101","article-title":"Transplanted human fetal neural stem cells survive, migrate, and differentiate in ischemic rat cerebral cortex","volume":"101","author":"Kelly","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"B60","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/nature23664","article-title":"Human iPS cell-derived dopaminergic neurons function in a primate Parkinson's disease model","volume":"548","author":"Kikuchi","year":"2017","journal-title":"Nature"},{"key":"B61","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/glia.20731","article-title":"Neuroprotective effects of human mesenchymal stem cells on dopaminergic neurons through anti-inflammatory action","volume":"57","author":"Kim","year":"2009","journal-title":"Glia"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1002\/sctm.18-0039","article-title":"Human genomic safe harbors and the suicide gene-based safeguard system for iPSC-based cell therapy","volume":"8","author":"Kimura","year":"2019","journal-title":"Stem Cells Transl. Med"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1111\/ajt.12712","article-title":"Renal transplantation using belatacept without maintenance steroids or calcineurin inhibitors","volume":"14","author":"Kirk","year":"2014","journal-title":"Am. J. Transplant"},{"key":"B64","doi-asserted-by":"publisher","first-page":"a008888","DOI":"10.1101\/cshperspect.a008888","article-title":"Genetics of Parkinson's disease","volume":"2","author":"Klein","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.2147\/NDT.S46583","article-title":"Current perspectives on deep brain stimulation for severe neurological and psychiatric disorders","volume":"11","author":"Kocabicak","year":"2015","journal-title":"Neuropsychiatr. Dis. Treat"},{"key":"B66","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.stemcr.2014.05.017","article-title":"Focal transplantation of human iPSC-derived glial-rich neural progenitors improves lifespan of ALS mice","volume":"3","author":"Kondo","year":"2014","journal-title":"Stem Cell Rep"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1056\/NEJM199504273321702","article-title":"Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease","volume":"332","author":"Kordower","year":"1995","journal-title":"N. Engl. J. Med"},{"key":"B68","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nature10648","article-title":"Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease","volume":"480","author":"Kriks","year":"2011","journal-title":"Nature"},{"key":"B69","doi-asserted-by":"publisher","first-page":"e166","DOI":"10.1371\/journal.pone.0000166","article-title":"Alloimmunisation to donor antigens and immune rejection following foetal neural grafts to the brain in patients with huntington's disease","volume":"2","author":"Krystkowiak","year":"2007","journal-title":"PLoS ONE"},{"key":"B70","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.molimm.2012.07.009","article-title":"Alternative peptide repertoire of HLA-E reveals a binding motif that is strikingly similar to HLA-A2","volume":"53","author":"Lampen","year":"2013","journal-title":"Mol. Immunol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"e00972","DOI":"10.1002\/brb3.972","article-title":"Human iNPC therapy leads to improvement in functional neurologic outcomes in a pig ischemic stroke model","volume":"8","author":"Lau","year":"2018","journal-title":"Brain Behav"},{"key":"B72","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/0306-4522(90)90413-X","article-title":"Mechanisms of allograft rejection in the rat brain","volume":"37","author":"Lawrence","year":"1990","journal-title":"Neuroscience"},{"key":"B73","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.scr.2018.06.002","article-title":"Generation of gene-corrected iPSC line from Parkinson's disease patient iPSC line with alpha-SNCA A53T mutation","volume":"30","author":"Lee","year":"2018","journal-title":"Stem Cell Res"},{"key":"B74","doi-asserted-by":"publisher","first-page":"124r","DOI":"10.1126\/scitranslmed.3003509","article-title":"Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation","volume":"4","author":"Leventhal","year":"2012","journal-title":"Sci. Transl. Med"},{"key":"B75","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1097\/TP.0000000000000605","article-title":"Immune reconstitution\/immunocompetence in recipients of kidney plus hematopoietic stem\/facilitating cell transplants","volume":"99","author":"Leventhal","year":"2015","journal-title":"Transplantation"},{"key":"B76","doi-asserted-by":"publisher","first-page":"10195","DOI":"10.1093\/nar\/gky804","article-title":"Highly efficient genome editing via CRISPR-Cas9 in human pluripotent stem cells is achieved by transient BCL-XL overexpression","volume":"46","author":"Li","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"B77","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/s41586-018-0733-7","article-title":"Linking a cell-division gene and a suicide gene to define and improve cell therapy safety","volume":"563","author":"Liang","year":"2018","journal-title":"Nature"},{"key":"B78","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1001\/archneur.1989.00520420033021","article-title":"Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease: a detailed account of methodology and a 6-month follow-up","volume":"46","author":"Lindvall","year":"1989","journal-title":"Arch. Neurol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.3390\/ijms21072481","article-title":"Targeted integration of inducible caspase-9 in human iPSCs allows efficient in vitro clearance of iPSCs and iPSC-macrophages","volume":"21","author":"Lipus","year":"2020","journal-title":"Int. J. Mol. Sci"},{"key":"B80","doi-asserted-by":"publisher","first-page":"645","DOI":"10.3389\/fimmu.2017.00645","article-title":"The immunogenicity and immune tolerance of pluripotent stem cell derivatives","volume":"8","author":"Liu","year":"2017","journal-title":"Front. Immunol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1593\/neo.101684","article-title":"Human leukocyte antigen E contributes to protect tumor cells from lysis by natural killer cells","volume":"13","author":"lo Monaco","year":"2011","journal-title":"Neoplasia"},{"key":"B82","doi-asserted-by":"publisher","first-page":"931","DOI":"10.3171\/jns.1997.86.6.0931","article-title":"Long-term improvement in patients with severe Parkinson's disease after implantation of fetal ventral mesencephalic tissue in a cavity of the caudate nucleus: 5-Year follow up in 10 patients","volume":"86","author":"L\u00f3pez-Lozano","year":"1997","journal-title":"J. Neurosurg"},{"key":"B83","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.it.2015.08.006","article-title":"Revisiting the mechanisms of CNS immune privilege","volume":"36","author":"Louveau","year":"2015","journal-title":"Trends Immunol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.brainresprot.2005.03.002","article-title":"Therapeutic benefit of TH-engineered mesenchymal stem cells for Parkinson's disease","volume":"15","author":"Lu","year":"2005","journal-title":"Brain Res. Protoc"},{"key":"B85","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1007\/s12015-013-9457-0","article-title":"Generating hypoimmunogenic human embryonic stem cells by the disruption of beta 2-microglobulin","volume":"9","author":"Lu","year":"2015","journal-title":"Stem Cell Rev. Rep"},{"key":"B86","doi-asserted-by":"publisher","first-page":"592","DOI":"10.3171\/jns.1998.89.4.0592","article-title":"Fatal cyst formation after fetal mesencephalic allograft transplant for Parkinson's disease","volume":"89","author":"Mamelak","year":"1998","journal-title":"J. Neurosurg"},{"key":"B87","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/sctm.18-0088","article-title":"A comprehensive analysis of protocols for deriving dopaminergic neurons from human pluripotent stem cells","volume":"8","author":"Marton","year":"2019","journal-title":"Stem Cells Transl. Med"},{"key":"B88","doi-asserted-by":"publisher","first-page":"e010239","DOI":"10.1161\/JAHA.118.010239","article-title":"Human leukocyte antigen class I and II knockout human induced pluripotent stem cell-derived cells: universal donor for cell therapy","volume":"7","author":"Mattapally","year":"2018","journal-title":"J. Am. Heart Assoc"},{"key":"B89","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.neuron.2008.10.010","article-title":"Mitochondria in neuroplasticity and neurological disorders","volume":"60","author":"Mattson","year":"2008","journal-title":"Neuron"},{"key":"B90","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.3389\/fnins.2019.01310","article-title":"ALS genetics, mechanisms, and therapeutics: where are we now?","volume":"13","author":"Mejzini","year":"2019","journal-title":"Front. Neurosci"},{"key":"B91","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1093\/brain\/awh510","article-title":"Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease","volume":"128","author":"Mendez","year":"2005","journal-title":"Brain"},{"key":"B92","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.4049\/jimmunol.172.5.2731","article-title":"Of mice and not men: differences between mouse and human immunology","volume":"172","author":"Mestas","year":"2004","journal-title":"J. Immunol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.tim.2011.11.002","article-title":"The pig: a model for human infectious diseases","volume":"20","author":"Meurens","year":"2011","journal-title":"Trends Microbiol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1089\/crispr.2019.0024","article-title":"Genetic protection modifications: moving beyond the binary distinction between therapy and enhancement for human genome editing","volume":"2","author":"Mikkelsen","year":"2019","journal-title":"Cris J"},{"key":"B95","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s00239-004-0046-3","article-title":"Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic elements","volume":"60","author":"Mojica","year":"2005","journal-title":"J. Mol. Evol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"4200","DOI":"10.1182\/blood.V99.11.4200","article-title":"The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors","volume":"99","author":"Morishima","year":"2002","journal-title":"Blood"},{"key":"B97","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.stemcr.2013.08.007","article-title":"Direct comparison of autologous and allogeneic transplantation of IPSC-derived neural cells in the brain of a nonhuman primate","volume":"1","author":"Morizane","year":"2013","journal-title":"Stem Cell Rep"},{"key":"B98","doi-asserted-by":"publisher","first-page":"281","DOI":"10.22074\/cellj.2016.4324","article-title":"Current biosafety considerations in stem cell therapy","volume":"18","author":"Mousavinejad","year":"2016","journal-title":"Cell J"},{"key":"B99","year":"2014","journal-title":"Stem Cell Transplant Reverses Sickle Cell Disease in Adults 2019"},{"key":"B100","doi-asserted-by":"publisher","first-page":"6999","DOI":"10.1073\/pnas.1006087107","article-title":"MHC class I molecules are present both pre- and postsynaptically in the visual cortex during postnatal development and in adulthood","volume":"107","author":"Needleman","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"B101","doi-asserted-by":"publisher","first-page":"8472","DOI":"10.1038\/s41598-020-65577-x","article-title":"Generation and characterization of HLA-universal platelets derived from induced pluripotent stem cells","volume":"10","author":"Norbnop","year":"2020","journal-title":"Sci. Rep"},{"key":"B102","doi-asserted-by":"publisher","first-page":"4811","DOI":"10.1038\/s41598-019-41121-4","article-title":"Highly efficient genome editing for single-base substitutions using optimized ssODNs with Cas9-RNPs","volume":"9","author":"Okamoto","year":"2019","journal-title":"Sci. Rep"},{"key":"B103","doi-asserted-by":"publisher","first-page":"dmm030783","DOI":"10.1242\/dmm.030783","article-title":"Genetically engineered pigs as models for human disease","volume":"11","author":"Perleberg","year":"2018","journal-title":"Dis. Model. Mech"},{"key":"B104","doi-asserted-by":"publisher","first-page":"4578","DOI":"10.1074\/jbc.R113.516419","article-title":"Genomic instability in pluripotent stem cells: implications for clinical applications","volume":"289","author":"Peterson","year":"2014","journal-title":"J. Biol. Chem"},{"key":"B105","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1038\/16060","article-title":"Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient","volume":"2","author":"Piccini","year":"1999","journal-title":"Nat. Neurosci"},{"key":"B106","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.scr.2016.08.002","article-title":"Generation of a gene-corrected isogenic control cell line from an alzheimer's disease patient iPSC line carrying a A79V mutation in PSEN1","volume":"17","author":"Pires","year":"2016","journal-title":"Stem Cell Res"},{"key":"B107","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.dib.2017.04.001","article-title":"Data on overlapping brain disorders and emerging drug targets in human dopamine receptors interaction network","volume":"12","author":"Podder","year":"2017","journal-title":"Data Br"},{"key":"B108","doi-asserted-by":"publisher","first-page":"eaaj2013","DOI":"10.1126\/scitranslmed.aaj2013","article-title":"Molecular remission of infant B-ALL after infusion of universal TALEN gene-edited CAR T cells","volume":"9","author":"Qasim","year":"2017","journal-title":"Sci. Transl. Med"},{"key":"B109","doi-asserted-by":"crossref","first-page":"75","DOI":"10.5772\/66353","article-title":"Porcine model of Huntington's disease","volume-title":"Huntington's Disease - Molecular Pathogenesis and Current Models","author":"Rausova","year":"2017"},{"key":"B110","doi-asserted-by":"publisher","first-page":"20920","DOI":"10.1073\/pnas.0710265105","article-title":"Embryonic stem cell-derived tissues are immunogenic but their inherent immune privilege promotes the induction of tolerance","volume":"104","author":"Robertson","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"B111","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.3174\/ajnr.A0644","article-title":"A three-year study of brain atrophy after autologous hematopoietic stem cell transplantation in rapidly evolving secondary progressive multiple sclerosis","volume":"28","author":"Rocca","year":"2007","journal-title":"Am. J. Neuroradiol"},{"key":"B112","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.stem.2013.11.014","article-title":"An effective approach to prevent immune rejection of human ESC-derived allografts","volume":"14","author":"Rong","year":"2014","journal-title":"Cell Stem Cell"},{"key":"B113","doi-asserted-by":"publisher","first-page":"34","DOI":"10.21037\/sci.2019.08.11","article-title":"A revealing review of mesenchymal stem cells therapy, clinical perspectives and Modification strategies","volume":"6","author":"Saeedi","year":"2019","journal-title":"Stem Cell Investig"},{"key":"B114","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s10571-019-00761-w","article-title":"CRISPR system: a high-throughput toolbox for research and treatment of Parkinson's disease","volume":"40","author":"Safari","year":"2020","journal-title":"Cell. Mol. Neurobiol"},{"key":"B115","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1111\/ajt.15700","article-title":"Applicability, safety, and biological activity of regulatory T cell therapy in liver transplantation","volume":"20","author":"S\u00e1nchez-Fueyo","year":"2020","journal-title":"Am. J. Transplant"},{"key":"B116","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1056\/NEJMoa1915872","article-title":"Personalized iPSC-derived dopamine progenitor cells for Parkinson's disease","volume":"382","author":"Schweitzer","year":"2020","journal-title":"N. Engl. J. Med"},{"key":"B117","doi-asserted-by":"publisher","first-page":"82","DOI":"10.2174\/157488811795495486","article-title":"Mesenchymal stem cells neuronal differentiation ability: a real perspective for nervous system repair?","volume":"6","author":"Scuteri","year":"2011","journal-title":"Curr. Stem Cell Res. Ther"},{"key":"B118","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1006\/smim.1995.0015","article-title":"Missing self recognition by natural killer cells in mhc class i transgenic mice. a =receptor calibration\u2018 model for how effector cells adapt to self","volume":"7","author":"Sentman","year":"1995","journal-title":"Semin. Immunol"},{"key":"B119","volume-title":"Transplanting a Face: Notes on a Life in Medicine","author":"Siemionow","year":"2018"},{"key":"B120","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3389\/fnint.2011.00079","article-title":"Long-lasting effects of human mesenchymal stem cell systemic administration on pain-like behaviors, cellular, and biomolecular modifications in neuropathic mice","volume":"5","author":"Siniscalco","year":"2011","journal-title":"Front. Integr. Neurosci"},{"key":"B121","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3389\/fncel.2018.00072","article-title":"An inflammation-centric view of neurological disease: beyond the neuron","volume":"12","author":"Skaper","year":"2018","journal-title":"Front. Cell. Neurosci"},{"key":"B122","doi-asserted-by":"publisher","first-page":"721","DOI":"10.2217\/rme.12.40","article-title":"Assessing commercial opportunities for autologous and allogeneic cell-based products","volume":"7","author":"Smith","year":"2012","journal-title":"Regen. Med"},{"key":"B123","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.cell.2011.06.019","article-title":"Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations","volume":"146","author":"Soldner","year":"2011","journal-title":"Cell"},{"key":"B124","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1172\/JCI93924","article-title":"Cografting astrocytes improves cell therapeutic outcomes in a Parkinson's disease model","volume":"128","author":"Song","year":"2018","journal-title":"J. Clin. Invest"},{"key":"B125","doi-asserted-by":"crossref","first-page":"161","DOI":"10.15586\/codonpublications.parkinsonsdisease.2018.ch9","article-title":"Stem cell treatments for Parkinson's disease","volume-title":"in Parkinson's Disease: Pathogenesis and Clinical Aspects","author":"Stoker","year":"2018"},{"key":"B126","doi-asserted-by":"publisher","first-page":"eaam6651","DOI":"10.1126\/scitranslmed.aam6651","article-title":"Survival of syngeneic and allogeneic iPSC\u2013derived neural precursors after spinal grafting in minipigs","volume":"10","author":"Strnadel","year":"2018","journal-title":"Sci. Transl. Med"},{"key":"B127","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/pr.2017.254","article-title":"Cell therapy for diverse central nervous system disorders: Inherited metabolic diseases and autism","volume":"83","author":"Sun","year":"2018","journal-title":"Pediatr. Res"},{"key":"B128","first-page":"213","article-title":"Strategies for bringing stem cell-derived dopamine neurons to the clinic: the kyoto trial","volume-title":"in Progress in Brain Research","author":"Takahashi","year":"2017"},{"key":"B129","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"B130","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jchemneu.2017.03.003","article-title":"The use of non-steroidal anti-inflammatory drugs in neurological diseases","volume":"87","author":"Terzi","year":"2018","journal-title":"J. Chem. Neuroanat"},{"key":"B131","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1056\/NEJM195709122571102","article-title":"Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy","volume":"257","author":"Thomas","year":"1957","journal-title":"N. Engl. J. Med"},{"key":"B132","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1016\/S0092-8674(02)00696-7","article-title":"Genetic control of MHC class II expression","volume":"109","author":"Ting","year":"2002","journal-title":"Cell"},{"key":"B133","first-page":"445","article-title":"Gaspare tagliacozzi, pioneer of plastic surgery and the spread of his technique throughout Europe in \u201cde curtorum chirurgia per insitionem.\u201d","volume":"18","author":"Tomba","year":"2014","journal-title":"Eur. Rev. Med. Pharmacol. Sci"},{"key":"B134","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1182\/blood-2013-03-478255","article-title":"Toward eliminating HLA class i expression to generate universal cells from allogeneic donors","volume":"122","author":"Torikai","year":"2013","journal-title":"Blood"},{"key":"B135","doi-asserted-by":"publisher","first-page":"573","DOI":"10.3389\/fimmu.2019.00573","article-title":"New paradigm in the role of regulatory T cells during pregnancy","volume":"10","author":"Tsuda","year":"2019","journal-title":"Front. Immunol"},{"key":"B136","doi-asserted-by":"publisher","first-page":"24251","DOI":"10.1038\/srep24251","article-title":"MHC-class-II are expressed in a subpopulation of human neural stem cells in vitro in an IFN\u00ce 3-independent fashion and during development","volume":"6","author":"Vagaska","year":"2016","journal-title":"Sci. Rep"},{"key":"B137","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.trsl.2009.07.006","article-title":"Open-labeled study of unilateral autologous bone-marrow-derived mesenchymal stem cell transplantation in Parkinson's disease","volume":"155","author":"Venkataramana","year":"2010","journal-title":"Transl. Res"},{"key":"B138","doi-asserted-by":"publisher","first-page":"931902","DOI":"10.1155\/2012\/931902","article-title":"Bilateral transplantation of allogenic adult human bone marrow-derived mesenchymal stem cells into the subventricular zone of Parkinson's disease: a pilot clinical study","volume":"2012","author":"Venkataramana","year":"2012","journal-title":"Stem Cells Int"},{"key":"B139","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.5966\/sctm.2015-0049","article-title":"Targeted disruption of the \u03b2 2 -microglobulin gene minimizes the immunogenicity of human embryonic stem cells","volume":"4","author":"Wang","year":"2015","journal-title":"Stem Cells Transl. Med"},{"key":"B140","unstructured":"Global burden of neurological disorders estimates and projections2739Neurological Disorders: Public Health Challenges2006"},{"key":"B141","doi-asserted-by":"publisher","first-page":"146615","DOI":"10.1016\/j.brainres.2019.146615","article-title":"The neural stem cell secretome and its role in brain repair","volume":"1729","author":"Willis","year":"2020","journal-title":"Brain Res"},{"key":"B142","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.it.2015.11.005","article-title":"Understanding stem cell immunogenicity in therapeutic applications","volume":"37","author":"Wood","year":"2016","journal-title":"Trends Immunol"},{"key":"B143","doi-asserted-by":"publisher","first-page":"14053","DOI":"10.1038\/mtm.2014.53","article-title":"Development of an inducible caspase-9 safety switch for pluripotent stem cell\u2013based therapies","volume":"1","author":"Wu","year":"2014","journal-title":"Mol Ther Methods Clin Dev"},{"key":"B144","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.stem.2019.02.005","article-title":"Targeted disruption of HLA genes via CRISPR-Cas9 generates iPSCs with enhanced immune compatibility","volume":"24","author":"Xu","year":"2019","journal-title":"Cell Stem Cell"},{"key":"B145","doi-asserted-by":"publisher","first-page":"11649","DOI":"10.1038\/s41598-018-30227-w","article-title":"Efficient homology-directed gene editing by CRISPR\/Cas9 in human stem and primary cells using tube electroporation","volume":"8","author":"Xu","year":"2018","journal-title":"Sci. Rep"},{"key":"B146","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1038\/mt.2015.100","article-title":"An inducible caspase-9 suicide gene to improve the safety of therapy using human induced pluripotent stem cells","volume":"23","author":"Yagyu","year":"2015","journal-title":"Mol. Ther"},{"key":"B147","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1038\/s41388-019-1045-6","article-title":"MHC class I dysfunction of glioma stem cells escapes from CTL-mediated immune response via activation of Wnt\/\u03b2-catenin signaling pathway","volume":"39","author":"Yang","year":"2020","journal-title":"Oncogene"},{"key":"B148","doi-asserted-by":"publisher","first-page":"967","DOI":"10.4049\/jimmunol.179.2.967","article-title":"Induction of regulatory T cells and dominant tolerance by dendritic cells incapable of full activation","volume":"179","author":"Yates","year":"2007","journal-title":"J. Immunol"},{"key":"B149","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.brainres.2013.07.001","article-title":"The spatio-temporal expression of MHC class i molecules during human hippocampal formation development","volume":"1529","author":"Zhang","year":"","journal-title":"Brain Res"},{"key":"B150","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s11064-012-0916-9","article-title":"The expression patterns of mhc class i molecules in the developmental human visual system","volume":"38","author":"Zhang","year":"","journal-title":"Neurochem. Res"},{"key":"B151","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1161\/STROKEAHA.110.593129","article-title":"Delayed administration of human umbilical tissue-derived cells improved neurological functional recovery in a rodent model of focal ischemia","volume":"42","author":"Zhang","year":"2011","journal-title":"Stroke"},{"key":"B152","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.stemcr.2017.01.012","article-title":"Patient iPSC-derived neurons for disease modeling of frontotemporal dementia with mutation in CHMP2B","volume":"8","author":"Zhang","year":"2017","journal-title":"Stem Cell Rep"},{"key":"B153","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.scr.2014.08.004","article-title":"Heterelogous expression of mutated HLA-G decreases immunogenicity of human embryonic stem cells and their epidermal derivatives","volume":"13","author":"Zhao","year":"2014","journal-title":"Stem Cell Res"},{"key":"B154","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.stem.2015.07.021","article-title":"Humanized mice reveal differential immunogenicity of cells derived from autologous induced pluripotent stem cells","volume":"17","author":"Zhao","year":"2015","journal-title":"Cell Stem Cell"}],"container-title":["Frontiers in Genome Editing"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgeed.2020.623717\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T18:44:58Z","timestamp":1610563498000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgeed.2020.623717\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,12]]},"references-count":154,"alternative-id":["10.3389\/fgeed.2020.623717"],"URL":"https:\/\/doi.org\/10.3389\/fgeed.2020.623717","relation":{},"ISSN":["2673-3439"],"issn-type":[{"value":"2673-3439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,12]]},"article-number":"623717"}}